TKG Advisors »

Vertex Pharmaceuticals Incorporated shares owned by TKG Advisors

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by TKG Advisors from 13F filings

Historical chart of TKG Advisors investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by TKG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by TKG Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $290k 624 465.08
2024-06-30 $300k 640 468.72
2024-03-31 $317k 759 418.01
2023-12-31 $315k 773 406.89
2023-09-30 $315k 907 347.74
2023-06-30 $317k 902 351.91
2023-03-31 $426k 1.4k 315.07
2022-12-31 $390k 1.4k 288.78

More positions owned by TKG Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Index Fds Value Etf (VTV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Msci Eurzone Etf (EZU)
Capital Group Intl Focus Eqt Shs Creation Uni (CGXU)
Trane Technologies SHS (TT)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
Jones Lang LaSalle Incorporated (JLL)
American Express Company (AXP)
NVIDIA Corporation (NVDA)
Capital One Financial (COF)
Cirrus Logic (CRUS)
Broadcom (AVGO)

View all positions for TKG Advisors

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Morgan Stanley
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated